C. Linnemann

发表

TIL therapy broadens the tumor-reactive CD8+ T cell compartment in melanoma patients

T. Schumacher, M. V. van Buuren, G. Kenter, 2012, Oncoimmunology.

Peptide Splicing in the Proteasome Creates a Novel Type of Antigen with an Isopeptide Linkage

T. Schumacher, B. Rodenko, H. Ovaa, 2015, The Journal of Immunology.

Towards error-free profiling of immune repertoires

Mikhail Shugay, Ton N Schumacher, Dmitriy A Bolotin, 2014, Nature Methods.

Pairing of T‐cell receptor chains via emulsion PCR

Mikhail Shugay, O. Britanova, T. Schumacher, 2013, European journal of immunology.

Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy

T. Schumacher, J. Haanen, W. Uckert, 2010, Nature Medicine.

Blockade of TGF-b Signaling Greatly Enhances the Efficacy of TCR Gene Therapy of Cancer

T. Schumacher, G. Bendle, C. Linnemann, 2013 .

RNAi-mediated TCR knockdown prevents autoimmunity in mice caused by mixed TCR dimers following TCR gene transfer.

T. Schumacher, W. Uckert, G. Bendle, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies

N. Croft, A. Purcell, G. Bendle, 2018, Journal of Immunotherapy for Cancer.

TCR repertoires of intratumoral T‐cell subsets

T. Schumacher, R. Mezzadra, C. Linnemann, 2014, Immunological reviews.

Anti–CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response

S. H. van der Burg, T. Schumacher, M. Welters, 2014, Science Translational Medicine.

High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma

Michael R Stratton, Arno Velds, Hergen Spits, 2014, Nature Medicine.

High-throughput identification of antigen-specific TCRs by TCR gene capture

T. Schumacher, D. Chudakov, C. Blank, 2013, Nature Medicine.

Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers

T. Schumacher, G. Kenter, B. Nelson, 2018, Nature Medicine.

Adenosine regulates CD8 T‐cell priming by inhibition of membrane‐proximal T‐cell receptor signalling

B. Schraven, E. Endl, P. Knolle, 2009, Immunology.

T-cell receptor gene therapy: critical parameters for clinical success.

T. Schumacher, G. Bendle, C. Linnemann, 2011, The Journal of investigative dermatology.

Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7

T. Schumacher, B. Rodenko, H. Ovaa, 2008, Proceedings of the National Academy of Sciences.

Blockade of TGF-β Signaling Greatly Enhances the Efficacy of TCR Gene Therapy of Cancer

T. Schumacher, Ji-Ying Song, G. Bendle, 2013, The Journal of Immunology.

Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers

T. Schumacher, G. Kenter, B. Nelson, 2018, Nature Medicine.

T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide–MHC complexes

Morten Nielsen, Paolo Marcatili, Sine R Hadrup, 2018, Nature Biotechnology.

HLA Micropolymorphisms Strongly Affect Peptide–MHC Multimer–Based Monitoring of Antigen-Specific CD8+ T Cell Responses

T. Schumacher, G. Grotenbreg, P. Kvistborg, 2014, The Journal of Immunology.

Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules

T. Schumacher, B. Rodenko, H. Ovaa, 2015, The Journal of Immunology.

Presentation by MHC Class I Molecules Rules for High-Efficiency Spliced Peptide Definition of Proteasomal Peptide Splicing

T. Schumacher, B. Rodenko, H. Ovaa, 2015 .

The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer

S. H. van der Burg, T. Schumacher, M. Welters, 2022, Cancer Immunology, Immunotherapy.

How the proteasome cleaves and religates peptides to expand the antigen repertoire

T. Schumacher, K. Schuurman, A. Jong, 2010 .

Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

M. Stratton, S. Behjati, T. Schumacher, 2016, Nature Medicine.

Antiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: evidence for receptor-independent mechanisms

A. Schiedel, C. Müller, P. Knolle, 2013, Purinergic Signalling Purinergic Signalling.

HLA Micropolymorphisms Strongly Affect Peptide–MHC Multimer–Based Monitoring of Antigen-Specific CD8+ T Cell Responses

T. Schumacher, G. Grotenbreg, P. Kvistborg, 2014, The Journal of Immunology.

Antiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: evidence for receptor-independent mechanisms

A. Schiedel, C. Müller, P. Knolle, 2013, Purinergic Signalling.

TCR repertoires of intratumoral T‐cell subsets

T. Schumacher, R. Mezzadra, C. Linnemann, 2014, Immunological reviews.